Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Framework Convention on Tobacco Control

26.06.2003


The World Health Organization Framework Convention on Tobacco Control (FCTC) was signed by 40 countries and the European Community during the first week it opened for signature. Norway became the first country to accept the treaty.

"The fact that so many countries signed the Framework Convention on Tobacco Control in its first week demonstrates how strongly it is supported and how meaningful it is to diverse populations and situations," said Dr Gro Harlem Brundtland, Director-General, World Health Organization. "This group of early signatories is exemplary and others are encouraged to follow suit in the shortest possible time frame. It is only through a concerted worldwide effort that we can make global tobacco control happen. The benefits for health will be immense," she added.

The FCTC’s demand and supply reduction measures will protect billions in present and future generations worldwide from the devastating impact of tobacco consumption and exposure to tobacco smoke. Tobacco kills nearly 5 million people per year. Unless strong action is taken, the global escalation in smoking, including amongst children, adolescents and women, will impose an even larger burden of disease, disability and death, particularly on developing countries.



The countries that have signed the FCTC to date are: Algeria, Bangladesh, Botswana, Brazil, Burundi, Czech Republic, Democratic People’s Republic of Korea, Denmark, Egypt, Finland, France, Gambia, Ghana, Greece, Hungary, Iceland, Islamic Republic of Iran, Israel, Italy, Kuwait, Luxembourg, Malta, Marshall Islands, Mauritius, Mongolia, Mozambique, Netherlands, New Zealand, Norway, Palau, Paraguay, Qatar, Senegal, South Africa, Spain, Sweden, Thailand, the United Kingdom, Uruguay and Yemen. The European Community signed the FCTC as a regional economic integration organization.

High level officials, including a vice president and ministers, from 28 countries, plus the European Community, signed the Convention at a formal ceremony at WHO’s Geneva headquarters on 16 June, the first day the treaty opened for signature.

In addition to signing the FCTC, Norway accepted it on 16 June. Ratifcation, acceptance, approval and accession are international acts by which states that have already signed the FCTC establish on the international plane their consent to be bound by it. As soon as 39 more countries follow suit, the Convention will become law for those countries and thereafter, for other countries that become contracting parties to it.

Deposited with United Nations Secretary-General Kofi Annan, the FCTC will be available for signature at the United Nations headquarters in New York from 30 June 2003 to 29 June 2004. Several more countries have informed WHO of their intention to sign the FCTC in New York shortly.

For more information contact:

Ms Melinda Henry
Telephone: +41 (22) 791 2535
Mobile phone: +41 (79) 477 1738
Fax: +41 (22) 791 4858
Email: henrym@who.int

Melinda Henry | WHO
Further information:
http://www.who.int

More articles from Health and Medicine:

nachricht Biofilm discovery suggests new way to prevent dangerous infections
23.05.2017 | University of Texas at Austin

nachricht Another reason to exercise: Burning bone fat -- a key to better bone health
19.05.2017 | University of North Carolina Health Care

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Strathclyde-led research develops world's highest gain high-power laser amplifier

The world's highest gain high power laser amplifier - by many orders of magnitude - has been developed in research led at the University of Strathclyde.

The researchers demonstrated the feasibility of using plasma to amplify short laser pulses of picojoule-level energy up to 100 millijoules, which is a 'gain'...

Im Focus: Can the immune system be boosted against Staphylococcus aureus by delivery of messenger RNA?

Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.

Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....

Im Focus: A quantum walk of photons

Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.

The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....

Im Focus: Turmoil in sluggish electrons’ existence

An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.

We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...

Im Focus: Wafer-thin Magnetic Materials Developed for Future Quantum Technologies

Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.

Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Marine Conservation: IASS Contributes to UN Ocean Conference in New York on 5-9 June

24.05.2017 | Event News

AWK Aachen Machine Tool Colloquium 2017: Internet of Production for Agile Enterprises

23.05.2017 | Event News

Dortmund MST Conference presents Individualized Healthcare Solutions with micro and nanotechnology

22.05.2017 | Event News

 
Latest News

New insights into the ancestors of all complex life

29.05.2017 | Earth Sciences

New photocatalyst speeds up the conversion of carbon dioxide into chemical resources

29.05.2017 | Life Sciences

NASA's SDO sees partial eclipse in space

29.05.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>